Dividend Aristocrat J&J raises dividend for 60th year in 2022

Dividend Aristocrat Johnson & Johnson (JNJ) will increase its quarterly dividend by 6.6 percent to $1.13 per share in the second quarter of 2022. This marks the 60th year of higher dividends by the health care giant.

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share. The new dividend yield for JNJ is 2.5% at a stock price of $183. The stock hit a fresh all-time high on Tuesday. JNJ is a Dividend Aristocrat with more than 25 years in a row of higher dividends paid to shareholders.

"In recognition of our 2021 results, strong financial position, and confidence in the future of Johnson & Johnson, the Board of Directors has voted to increase the quarterly dividend for the 60th consecutive year," said Joaquin Duato, Chief Executive Officer of the company.

At the new rate, the indicated dividend on an annual basis is $4.52 per share compared to the previous rate of $4.24 per share. The next quarterly dividend is payable on June 7, 2022 to shareholders of record as of the close of business on May 24, 2022. The ex-dividend date is May 23, 2022.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Dividend Headlines